Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma

PHASE3RecruitingINTERVENTIONAL

Enrollment

504

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

November 15, 2027

Study Completion Date

January 15, 2028

Conditions

Asthma

Interventions

DRUG

MG-K10/Placebo

MG-K10 Humanized Monoclonal Antibody Injection

Trial Locations (1)

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors

lead

Shanghai Mabgeek Biotech.Co.Ltd

OTHER_GOV